Legal fights and loopholes could blunt Medicare’s new power to control drug prices
By Leslie Walker and Dan Gorenstein September 15, 2022 On Tuesday, the White House celebrated the passage of the the Inflation Reduction Act, a sweeping climate, tax and health care package passed in August. Among other measures, it grants Medicare historic new powers to control prescription drug prices. Democratic leaders like U.S. Sen. Chuck Schumer,… Read more »